HEMATOLOGIC
MALIGNANCIES

MEMBERSHIP RESOURCES

BECOME A MEMBER

EVENTS

VIEW EVENTS

Program Highlights

April 2025

Project EVOLVE: An international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Read More

March 2025

Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement

Read More

March 2025

Crohn's Disease-associated variant in laccase domain containing 1 (LACC1) modulates T cell gene expression, metabolism and T cell function

Read More

Overview

The Hematologic Malignancies (HEM) research program focuses on advancing our understanding of molecular pathogenesis and treatment of leukemias and lymphomas.Learn more about the program & goals